2019
DOI: 10.1172/jci.insight.121541
|View full text |Cite
|
Sign up to set email alerts
|

Human antigen R as a therapeutic target in pathological cardiac hypertrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
47
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(49 citation statements)
references
References 31 publications
1
47
1
Order By: Relevance
“…RNA was isolated from BAT as previously described [15] and poly(A) library preparation and sequencing were done by the CCHMC DNA sequencing and genotyping core. Sequence read mapping, principal component analysis, differential expression analysis, heat mapping, and generation of volcano plots were done using CLC Genomics Workbench (v. 20.0.2, Qiagen) as previously described [16]. The statistical significance threshold for expression between groups was defined as an FDR-corrected P-value less than or equal to 0.05 and a fold-change greater than or equal to 1.5.…”
Section: Rna-seq Analysismentioning
confidence: 99%
“…RNA was isolated from BAT as previously described [15] and poly(A) library preparation and sequencing were done by the CCHMC DNA sequencing and genotyping core. Sequence read mapping, principal component analysis, differential expression analysis, heat mapping, and generation of volcano plots were done using CLC Genomics Workbench (v. 20.0.2, Qiagen) as previously described [16]. The statistical significance threshold for expression between groups was defined as an FDR-corrected P-value less than or equal to 0.05 and a fold-change greater than or equal to 1.5.…”
Section: Rna-seq Analysismentioning
confidence: 99%
“…HuR activity is negligible in normal adult hearts, and thus cardiomyocyte specific deletion does not affect basal cardiac function, yet HuR deletion does reduce hypertrophy and cardiac functional decline in response to TAC. Importantly, the authors report clinical benefits from pharmacological HuR inhibition even when hypertrophy is already detectable [82].…”
Section: Au-rich Element Binding Proteinsmentioning
confidence: 95%
“…Elevation of inflammatory cytokines during cardiac hypertrophy has recently been observed to, at least partially, rely on translation of inflammatory genes mediated by enhanced stability of their mRNA by ARE-RNA binding proteins. The increase in ARE binding protein activity during the progression to heart failure is accompanied by their translocation from the nucleus to the cytoplasm [81,82]. One example of an ARE binding protein induced during human heart failure and in a mouse model of TAC induced pressure overload is brain-expressed X-linked protein 1 (BEX1).…”
Section: Au-rich Element Binding Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…While HuR increases the activity of pro-inflammatory genes like TNF-α, it also decreases the activity of anti-inflammatory genes like eNOS, a classical example of reciprocal regulation of different genes by the same ARE-BP to achieve maximal activation of pro-inflammatory immunogenic pathways [52]. Importantly, misregulation of HuR has also been shown to contribute to cardiac arrhythmias, fibrosis, and pathogenic remodeling during HF [53,54]. This further supports the idea that ARE misregulation can lead to cardiovascular damage.…”
Section: Au-rich Elementsmentioning
confidence: 99%